Cargando…

Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study

BACKGROUND: Our aim was to identify health-related quality-of-life (HRQoL) issues and symptoms in patients with haematological malignancies (HMs) and develop a conceptual framework to reflect the inter-relation between them. METHODS: A total of 129 patients with HMs were interviewed in a UK multicen...

Descripción completa

Detalles Bibliográficos
Autores principales: Goswami, Pushpendra, Oliva, Esther N., Ionova, Tatyana, Else, Roger, Kell, Jonathan, Fielding, Adele K., Jennings, Daniel M., Karakantza, Marina, Al-Ismail, Saad, Collins, Graham P., McConnell, Stewart, Langton, Catherine, Salek, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549153/
https://www.ncbi.nlm.nih.gov/pubmed/33101618
http://dx.doi.org/10.1177/2040620720955002
_version_ 1783592746851762176
author Goswami, Pushpendra
Oliva, Esther N.
Ionova, Tatyana
Else, Roger
Kell, Jonathan
Fielding, Adele K.
Jennings, Daniel M.
Karakantza, Marina
Al-Ismail, Saad
Collins, Graham P.
McConnell, Stewart
Langton, Catherine
Salek, Sam
author_facet Goswami, Pushpendra
Oliva, Esther N.
Ionova, Tatyana
Else, Roger
Kell, Jonathan
Fielding, Adele K.
Jennings, Daniel M.
Karakantza, Marina
Al-Ismail, Saad
Collins, Graham P.
McConnell, Stewart
Langton, Catherine
Salek, Sam
author_sort Goswami, Pushpendra
collection PubMed
description BACKGROUND: Our aim was to identify health-related quality-of-life (HRQoL) issues and symptoms in patients with haematological malignancies (HMs) and develop a conceptual framework to reflect the inter-relation between them. METHODS: A total of 129 patients with HMs were interviewed in a UK multicentre qualitative study. All interviews were audio recorded, transcribed and analysed using NVivo-11. RESULTS: Overall, 34 issues were reported by patients and were grouped into two parts: quality of life (QoL) and symptoms. The most prevalent HRQoL issues were: eating and drinking habits; social life; physical activity; sleep; and psychological well-being. Furthermore, most prevalent disease-related symptoms were: tiredness; feeling unwell; breathlessness; lack of energy; and back pain. The most prevalent treatment side effects were: tiredness; feeling sick; disturbance in sense of taste; and breathlessness. CONCLUSIONS: Both HMs and their treatments have a significant impact on patients’ HRQoL, in particular on issues such as job-role change, body image and impact on finances.
format Online
Article
Text
id pubmed-7549153
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-75491532020-10-22 Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study Goswami, Pushpendra Oliva, Esther N. Ionova, Tatyana Else, Roger Kell, Jonathan Fielding, Adele K. Jennings, Daniel M. Karakantza, Marina Al-Ismail, Saad Collins, Graham P. McConnell, Stewart Langton, Catherine Salek, Sam Ther Adv Hematol Original Research BACKGROUND: Our aim was to identify health-related quality-of-life (HRQoL) issues and symptoms in patients with haematological malignancies (HMs) and develop a conceptual framework to reflect the inter-relation between them. METHODS: A total of 129 patients with HMs were interviewed in a UK multicentre qualitative study. All interviews were audio recorded, transcribed and analysed using NVivo-11. RESULTS: Overall, 34 issues were reported by patients and were grouped into two parts: quality of life (QoL) and symptoms. The most prevalent HRQoL issues were: eating and drinking habits; social life; physical activity; sleep; and psychological well-being. Furthermore, most prevalent disease-related symptoms were: tiredness; feeling unwell; breathlessness; lack of energy; and back pain. The most prevalent treatment side effects were: tiredness; feeling sick; disturbance in sense of taste; and breathlessness. CONCLUSIONS: Both HMs and their treatments have a significant impact on patients’ HRQoL, in particular on issues such as job-role change, body image and impact on finances. SAGE Publications 2020-10-07 /pmc/articles/PMC7549153/ /pubmed/33101618 http://dx.doi.org/10.1177/2040620720955002 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Goswami, Pushpendra
Oliva, Esther N.
Ionova, Tatyana
Else, Roger
Kell, Jonathan
Fielding, Adele K.
Jennings, Daniel M.
Karakantza, Marina
Al-Ismail, Saad
Collins, Graham P.
McConnell, Stewart
Langton, Catherine
Salek, Sam
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study
title Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study
title_full Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study
title_fullStr Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study
title_full_unstemmed Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study
title_short Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study
title_sort quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549153/
https://www.ncbi.nlm.nih.gov/pubmed/33101618
http://dx.doi.org/10.1177/2040620720955002
work_keys_str_mv AT goswamipushpendra qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT olivaesthern qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT ionovatatyana qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT elseroger qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT kelljonathan qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT fieldingadelek qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT jenningsdanielm qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT karakantzamarina qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT alismailsaad qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT collinsgrahamp qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT mcconnellstewart qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT langtoncatherine qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy
AT saleksam qualityoflifeissuesandsymptomsreportedbypatientslivingwithhaematologicalmalignancyaqualitativestudy